Location History:
- Lothian, GB (2013)
- Edinburgh, GB (2002 - 2017)
Company Filing History:
Years Active: 2002-2017
Title: Innovations of Brian Robert Walker
Introduction
Brian Robert Walker is a prominent inventor based in Edinburgh, GB. He has made significant contributions to the field of therapeutic compounds, particularly in the development of inhibitors for 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). With a total of 14 patents to his name, Walker's work has the potential to impact various medical conditions.
Latest Patents
One of Walker's latest patents involves the creation of 3,3-disubstituted-(8-aza-bicyclo[3.2.1]oct-8-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanones. These compounds serve as inhibitors of 11β-HSD1 and are designed to treat disorders such as type 2 diabetes, obesity, and cognitive impairments, including Alzheimer's disease. The invention also encompasses pharmaceutical compositions that utilize these compounds for both in vitro and in vivo applications.
Career Highlights
Walker is affiliated with The University of Edinburgh, where he conducts research and develops innovative therapeutic solutions. His work is characterized by a strong focus on addressing metabolic syndromes and central nervous system disorders through novel chemical compounds.
Collaborations
Some of Walker's notable coworkers include Jonathan Robert Seckl and Christopher Richard Watkin Edwards. Their collaborative efforts contribute to the advancement of research in therapeutic compounds and their applications.
Conclusion
Brian Robert Walker's innovative work in the field of therapeutic compounds showcases his dedication to improving health outcomes through scientific research. His contributions are paving the way for new treatments for various medical conditions.